MedPath
NMPA Approval

Ranitidine Hydrochloride Effervescent Granules

国药准字H20030262

August 9, 2024

Drug Information

盐酸雷尼替丁泡腾颗粒

康恩贝

颗粒剂

每袋1.5g(含雷尼替丁0.15g)

化学药品

August 9, 2024

Company Information

Applicant Company

杭州市滨江区长河街道滨康路568号

Manufacturing Company

杭州市滨江区长河街道滨康路568号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁泡腾颗粒 - NMPA 批准文号 | MedPath